undefined

Yvonne Greenstreet

CEO of Alnylam Pharmaceuticals, a pioneering biopharmaceutical company focused on RNA interference therapeutics. She has over 25 years of experience in the biopharma industry and a global background from London to Ghana.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app